The bright elusive butterfly of value in health technology development; Comment on “Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies”
The current system of health technology development is characterised by multiple misalignments. The “supply” side (innovation policy-makers, entrepreneurs, investors) and the “demand” side (health policy-makers, regulators, health technology assessment, purchasers) operate under different – and conf...
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Published: |
Kerman University of Medical Sciences
2017
|